Actavis PLC agreed to pay about $66 billion for Allergan Inc., after the maker of Botox turned to the drugmaker to repel a hostile advance from Valeant Pharmaceuticals International Inc. Actavis will pay $219 a share in cash and stock for...
Bloomberg News Service, Orange County Register: Business
Mon, 11/17/2014 - 8:13am
Actavis PLC agreed to pay about $66 billion for Allergan Inc., after the maker of Botox turned to the drugmaker to repel a hostile advance from Valeant Pharmaceuticals International Inc. Actavis will pay $219 a share in cash and stock for...